DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Tokyo Big Sight

2018 年 11 月 11 日 9:30 上午 - 2018 年 11 月 13 日 5:40 下午

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

15th DIA Japan Annual Meeting 2018

Innovative technologies such as AI, big data/genomics, and cell/gene therapies are poised to transform healthcare product development across the globe – join us to discuss these topics.

[V5-S6] The Latest Trend of Vaccine Policy, Regulatory Regulation in Japan, the United States and Europe

Session Chair(s)

Nobuhiko  Okabe, MD

Nobuhiko Okabe, MD

Director General, Kawasaki City Institute for Public Health, Japan

Although vaccination has largely contributed to the improvement and promotion of public health, prevention of infection by vaccination will become increasingly important for the Tokyo Olympic Games to be held in 2020. In this session, we introduce the vaccination system and examination in Japan, the United States and Europe, and discuss how the differences in the system influence vaccination promotion from various viewpoints. We will also discuss experiences on benefits gained by vaccination and expectations for future vaccine administration.

Speaker(s)

Akihiko  Saitoh, MD

Akihiko Saitoh, MD

Professor, School of Medicine Department of Pediatrics, Niigata University, Japan

Immunization System in Japan - Recent Progress and Challenges -

Ercem S Atillasoy, MD

Ercem S Atillasoy, MD

Vice President, Merck & Co., Inc, United States

Regulatory Trends and Current Challenges for Vaccine Development in the USA

Shazia  Sheikh

Shazia Sheikh

Director, Communications & Government Affairs, Emerging Markets, GSK Vaccines, Belgium

Immunisation in Europe: an overview

Andrew  Otoo, PHARMD, MBA

Andrew Otoo, PHARMD, MBA

VP, Japan Vaccines Country Lead, Pfizer Japan Inc., Japan

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。